GPT Healthcare Ltd
GPT Healthcare Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #25 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
GPT Healthcare expects continued revenue growth driven by higher occupancy and improved specialty mix across hospitals. GPT Healthcare expects EBITDA margins to improve from 19% last year to around 21% in FY27, translating to an EBITDA of approximately INR 110-115 crores annually (including other income).
From GPT Healthcare Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- GPT Healthcare expects continued revenue growth driven by higher occupancy and improved specialty mix across hospitals.
- Mature hospitals show steady patient inflows with network occupancy at 45.5%, and 58.07% in mature hospitals excluding Raipur.
- Expansion projects like the 155-bed Jamshedpur hospital commissioning in Q4 FY27 and plans for a seventh hospital will increase capacity beyond 1,000 beds in 2 years.
- Specialty services, including liver transplants (around 10 per year initially at Raipur), oncology ramp-up, and robotic surgeries, are expected to drive higher ARPOB and patient volumes.
- Newer hospitals like Raipur and Dumdum are ramping up occupancy and revenue, with Dumdum targeting optimum occupancy by Q3 FY27.
2 more points from GPT Healthcare Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what GPT Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- GPT Healthcare is progressing on the construction of a 155-bed tertiary care hospital in Jamshedpur, expected to be commissioned in Q4 FY27.
- The company is evaluating opportunities for a seventh hospital, aiming to increase network capacity to over 1,000 beds in the next 2 years.
- Expansion plans include both acquisition and greenfield projects in Tier 1 and Tier 2 cities like Cuttack, Ranchi, Patna, Banaras, and Prayagraj.
- New hospitals such as Raipur and Jamshedpur are developed on an asset-light model, leasing customized buildings to reduce real estate investments.
2 more points from GPT Healthcare Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what GPT Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from GPT Healthcare Ltd's call on order book
Create a free account to keep reading this call
GPT Healthcare Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹126 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What GPT Healthcare's management said in earlier quarters
Others in Healthcare Services this season
- Aatmaj Health (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- Asarfi Hospital Ltd (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
GPT Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were GPT Healthcare Ltd Q1 FY27 results?
GPT Healthcare expects continued revenue growth driven by higher occupancy and improved specialty mix across hospitals. GPT Healthcare expects EBITDA margins to improve from 19% last year to around 21% in FY27, translating to an EBITDA of approximately INR 110-115 crores annually (including other income).
What is GPT Healthcare Ltd share price analysis?
GPT Healthcare Ltd currently shows a below-average growth signal. The stock trades at a P/E of 27.1 with a market cap of ₹1,281 Cr. Investors should review the full earnings analysis for detailed insights.
Is GPT Healthcare Ltd planning capital expenditure?
GPT Healthcare is progressing on the construction of a 155-bed tertiary care hospital in Jamshedpur, expected to be commissioned in Q4 FY27.
Keep GPT Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.